Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 349)
Posted On: 04/17/2020 6:56:51 AM
Post# of 36566
Posted By: docj
Re: skipper1072 #15275
Joe's response to me on the subject:

"Antiviral response is B cell epitopes only from those epitopes they make B cell peptides, big deal, so they are going for antibody result only, where is the long term memory, they have none, the cellular response creates the long term memory that’s iikey peptides and we also are going for B cell epitopes as well linked with iikey for a more robust response Humerol and cellular anywhere from 100-1000 times more effective, potent, and humologic that’s why ours is a complete vaccine, my opinion antibody (Humerol) won’t be enough, but hey she’s academia, and typically 2/3 percent of things that come from academia ever get commercialized and pharma doesn’t even look most of the time. I’m not worried about this one, or the RNAI, Cell Clamping, Humerol alone, or dna. However I wish we all win the world certainly needs it."















(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site